Faes Farma SA
MAD:FAE
Faes Farma SA
Operating Income
Faes Farma SA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Faes Farma SA
MAD:FAE
|
Operating Income
€108.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
Almirall SA
MAD:ALM
|
Operating Income
€49.6m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-21%
|
|
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
Operating Income
€179.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
33%
|
CAGR 10-Years
21%
|
|
|
Laboratorio Reig Jofre SA
MAD:RJF
|
Operating Income
€15m
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
|
|
L
|
Labiana Health SA
MAD:LAB
|
Operating Income
-€1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Faes Farma SA
Glance View
Faes Farma SA, a notable player in the pharmaceutical arena, has orchestrated its operations with the precision of a seasoned conductor. Rooted in Spain with an impressive international reach, the company blends research prowess with adept production capabilities. Central to its modus operandi is the development, manufacture, and commercialization of a wide range of pharmaceutical products and nutritional supplements. With science as its guiding star, Faes Farma dedicates substantial resources to research and development, ensuring a pipeline filled with innovative treatments that cater to diverse medical needs. The company has carved its niche by focusing on therapeutic areas such as allergy, dermatology, and the central nervous system, allowing it to create specialized solutions that resonate well with healthcare providers and patients alike. The company’s revenue engine is driven primarily by its robust product sales, enhanced by strategic partnerships and licensing agreements that bolster its market presence both in Spain and across global markets. Through rigorous production processes, Faes Farma ensures the delivery of high-quality medications, matching industry standards and fostering consumer trust. Additionally, its geographical diversification, with subsidiaries and distribution channels spreading across Europe, Latin America, and Africa, underpins its economic durability. By marrying innovation with strategic commercial tactics, Faes Farma has deftly navigated the complexities of the pharmaceutical landscape, ensuring not only profitability but also the sustained delivery of health-enhancing products to the global community.
See Also
What is Faes Farma SA's Operating Income?
Operating Income
108.5m
EUR
Based on the financial report for Dec 31, 2024, Faes Farma SA's Operating Income amounts to 108.5m EUR.
What is Faes Farma SA's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for Faes Farma SA have been 4% over the past three years , 7% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet